PATIENT_ID,MED_START,MED_END,MED_NAME
101,4/19/18,4/19/18,pembrolizumab
101,5/10/18,5/10/18,pembrolizumab
101,5/29/18,5/29/18,pembrolizumab
101,6/19/18,6/19/18,pembrolizumab
101,7/12/18,7/12/18,pembrolizumab
101,8/2/18,8/2/18,pembrolizumab
101,8/23/18,8/23/18,pembrolizumab
101,9/13/18,9/13/18,pembrolizumab
101,10/4/18,10/4/18,pembrolizumab
101,10/25/18,10/25/18,pembrolizumab
101,11/15/18,11/15/18,pembrolizumab
101,12/6/18,12/6/18,pembrolizumab
101,12/27/18,12/27/18,pembrolizumab
101,1/24/19,1/24/19,pembrolizumab
101,1/24/19,1/24/19,pemetrexed
101,1/24/19,1/24/19,CARBOplatin
101,2/14/19,2/14/19,pembrolizumab
101,2/14/19,2/14/19,pemetrexed
101,2/14/19,2/14/19,CARBOplatin
101,3/7/19,3/7/19,pembrolizumab
101,3/7/19,3/7/19,pemetrexed
101,3/7/19,3/7/19,CARBOplatin
101,3/28/19,3/28/19,pembrolizumab
101,3/28/19,3/28/19,pemetrexed
101,3/28/19,3/28/19,CARBOplatin
101,4/18/19,4/18/19,pembrolizumab
101,4/18/19,4/18/19,pemetrexed
2,1/14/18,1/14/18,nivolumab
2,2/3/18,2/3/18,nivolumab
2,2/18/18,2/18/18,nivolumab
2,3/4/18,3/4/18,nivolumab
2,3/4/18,3/4/18,CARBOplatin
2,3/18/18,3/18/18,nivolumab
2,3/18/18,3/18/18,CARBOplatin
2,4/1/18,4/1/18,CARBOplatin
2,4/1/18,4/1/18,nivolumab
2,4/14/18,4/14/18,nivolumab
2,4/14/18,4/14/18,CARBOplatin
2,4/29/18,4/29/18,nivolumab
2,4/29/18,4/29/18,CARBOplatin
2,5/14/18,5/14/18,cetuximab
2,5/21/18,5/21/18,cetuximab
2,5/28/18,5/28/18,cetuximab
2,6/4/18,6/4/18,cetuximab
2,6/11/18,6/11/18,cetuximab
2,6/18/18,6/18/18,cetuximab
2,6/25/18,6/25/18,cetuximab
2,7/2/18,7/2/18,cetuximab
2,7/10/18,7/10/18,cetuximab
2,7/15/18,7/15/18,cetuximab
2,7/30/18,7/30/18,cetuximab
2,8/7/18,8/7/18,cetuximab
2,8/13/18,8/13/18,cetuximab
2,8/20/18,8/20/18,cetuximab
2,8/27/18,8/27/18,cetuximab
2,9/4/18,9/4/18,cetuximab
2,9/10/18,9/10/18,cetuximab
2,9/17/18,9/17/18,cetuximab
2,9/24/18,9/24/18,cetuximab
2,10/2/18,10/2/18,cetuximab
2,10/8/18,10/8/18,cetuximab
2,10/8/18,10/8/18,cetuximab
2,10/16/18,10/16/18,cetuximab
2,10/22/18,10/22/18,cetuximab
2,11/12/18,11/12/18,durvalumab
2,11/26/18,11/26/18,durvalumab